Pharmesis International Equity 2024

Equity Details

Analyzing Pharmesis International's Equity

Pharmesis International's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Pharmesis International's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Pharmesis International's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Pharmesis International's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Pharmesis International’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Pharmesis International stock

What is the equity of Pharmesis International this year?

Pharmesis International has equity of 51.07 M CNY this year.

What was the equity of Pharmesis International compared to the previous year?

The equity of Pharmesis International has increased/decreased by -5.25% decreased compared to the previous year.

What impact does a high equity have on investors of Pharmesis International?

A high equity is advantageous for investors of Pharmesis International as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Pharmesis International?

A low equity can be a risk for investors of Pharmesis International, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Pharmesis International affect the company?

An increase in equity of Pharmesis International can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Pharmesis International affect the company?

A reduction in equity of Pharmesis International can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Pharmesis International?

Some factors that can affect the equity of Pharmesis International include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Pharmesis International so important for investors?

The equity of Pharmesis International is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Pharmesis International take to change the equity?

To change equity, Pharmesis International can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Pharmesis International pay?

Over the past 12 months, Pharmesis International paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Pharmesis International is expected to pay a dividend of 0 CNY.

What is the dividend yield of Pharmesis International?

The current dividend yield of Pharmesis International is .

When does Pharmesis International pay dividends?

Pharmesis International pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Pharmesis International?

Pharmesis International paid dividends every year for the past 0 years.

What is the dividend of Pharmesis International?

For the upcoming 12 months, dividends amounting to 0 CNY are expected. This corresponds to a dividend yield of 0 %.

In which sector is Pharmesis International located?

Pharmesis International is assigned to the 'Health' sector.

Wann musste ich die Aktien von Pharmesis International kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Pharmesis International from 9/19/2024 amounting to 0 CNY, you needed to have the stock in your portfolio before the ex-date on 9/19/2024.

When did Pharmesis International pay the last dividend?

The last dividend was paid out on 9/19/2024.

What was the dividend of Pharmesis International in the year 2023?

In the year 2023, Pharmesis International distributed 0 CNY as dividends.

In which currency does Pharmesis International pay out the dividend?

The dividends of Pharmesis International are distributed in CNY.